Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: A pilot study centred on pharmacist intervention and a patient information leaflet

Pharmaceutical Research

Volumn 31, Issue 8, 2014, Pages 1989-1999

  Donnelly, Ryan F ^a   Moffatt, Kurtis ^a   Alkilani, Ahlam Zaid ^a,b   Vicente Pérez, Eva M ^a   Barry, Johanne ^a   McCrudden, Maelíosa T C ^a   Woolfson, A David ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ZARQA UNIVERSITY   (Jordan)

Author keywords

microneedle; patient information leaflet; pharmacist; skin barrier; transepidermal water loss

Indexed keywords

HYDROGEL;

ADMINISTRATION AND DOSAGE; CHEMISTRY; DEVICES; DRUG EFFECTS; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HYDROGEL; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; MICROINJECTION; PATIENT EDUCATION; PHARMACIST; PILOT STUDY; PROCEDURES; PROFESSIONAL STANDARD; SKIN; TRANSDERMAL PATCH; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; FEMALE; HUMANS; HYDROGEL; MALE; MICROINJECTIONS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE; SELF ADMINISTRATION; SKIN; TRANSDERMAL PATCH; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893844186     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1301-y     Document Type: Article

References (31)

1. Donnelly RF, Singh TRR, Morrow DIJ, Woolfson AD. Microneedle-mediated transdermal and intradermal drug delivery. Chichester: John Wiley & Sons, Ltd; 2012.
2. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64:1547-68.
3. Al-Zahrani S, Zaric, McCrudden MT, Scott C, Kissenpfennig A, Donnelly RF. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv. 2012;9:541-50.
4. Tuan-Mahmood TM, McCrudden MT, Torrisi BM, McAlister E, Garland MJ, Singh TR, Donnelly RF. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013 In Press.
5. Greystone Associates. Microneedles in medicine: technology, devices, markets and prospects. Amherst: Greystone Associates; 2012.
6. Donnelly RF, Morrow DIJ, Singh TRR, Migalska K, McCarron PA, O'Mahony C, et al. Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev Ind Pharm. 2009;35:1242-54.
7. Donnelly RF, Majithiya R, Singh TRR, Morrow DIJ, Garland MJ, Demir YK, et al. Design and physicochemical characterisation of optimised polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res. 2011;28:41-57.
8. Migalska K, Morrow DIJ, Garland MJ, Thakur RRS, Woolfson AD, Donnelly RF. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res. 2011;28:1919-30.
9. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release. 2005;104:51-66.
10. Donnelly RF, Singh TRR, Garland MJ, Migalska K, Majithiy R, McCrudden CM, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22:4879-90.
11. Donnelly RF, Singh TR, Alkilani AZ, McCrudden MT, O'Neill S, O'Mahony C, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm. 2013;451:76-91.
12. Donnelly RF, Garland MJ, Morrow DIJ, Migalska K, Thakur RRS, Majithiya R, et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release. 2010;147:333-41.
13. Olatunji O, Das DB, Garland MJ, Belaid L, Donnelly RF. Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. J Pharm Sci. 2013;102:1209-21.
14. Li WZ, Huo MR, Zhou JP, Zhou YQ, Hao BH, Liu T, et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm. 2010;389:122-9.
15. Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004;37:1155-63.
16. Thakur RRS, Dunne NJ, Cunningham E, Donnelly RF. Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul. 2011;5:11-23.
17. Thakur RRS, Woolfson AD, Donnelly RF. Investigation of solute permeation across poly(ethylene glycol)-crosslinked poly (methyl vinyl ether-co-maleic acid) hydrogels. J Pharm Pharmacol. 2010;62:829-37.
18. Thakur RRS, Garland MJ, Migalska K, Caffarel-Salvador E, Shaikh R, Woolfson AD, et al. Influence of a pore-forming agent on swelling, network parameters and permeability of poly (ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: application in transdermal delivery systems. J Appl Polym Sci. 2012;125:2680-94.
19. Medicines & Healthcare products Regulatory Agency (2013) Quality Criteria for PILs http://www.mhra.gov.uk/Howweregulate/Medicines/Labelspatientinformationleafletsandpackaging. Accessed 21st April 2013.
20. Giudice EL, Campbell JD. Needle-free vaccine delivery. Adv Drug Deliv Rev. 2006;58:68-89.
21. Kalluri H, Kolli CS, Banga AK. Characterization of microchannels created by metal microneedles: formation and closure. AAPS J. 2011;13:473-81.
22. Kalluri H, Banga AK. Formation and closure of microchannels in skin following microporation. Pharm Res. 2011;28:82-94.
23. Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices. 2009;11:35-47.
24. Gomaa YA, Morrow DIJ, Garland MJ, Donnelly RF, El-Khordagui LK, Meidan VM. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol in Vitro. 2010;24:1971-8.
25. Abelson J, Forest P-G, Eyles J, Smith P, Martin E, Gauvin FP. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med. 2003;57:239-51.
26. Donnelly RF, Singh TRR, Tunney MM, Morrow DIJ, McCarro PA, O'Mahony C, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res. 2009;26:2513-22.
27. Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007;59:1152-61.
28. Ng KW, Pearton M, Coulman S, Anstey A, Gateley C, Morrissey A, et al. Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Vaccine. 2009;27:5948-55.
29. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585-94.
30. Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193-202.
31. Birchall JC, Clemo R, Anstey A, John DN. Microneedles in clinical practice-an exploratory study into the opinions of healthcare professionals and the public. Pharm Res. 2011;28:95-106.